Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bristol-Myers Squibb (BMY.US) climbs pre-market! Two experimental drugs achieve success in phase III clinical trials, accelerating pipeline diversification

Bristol-Myers Squibb (BMY.US) climbs pre-market! Two experimental drugs achieve success in phase III clinical trials, accelerating pipeline diversification

智通财经智通财经2026/10/12 12:36
Show original
It is reported by Zhitong Finance APP that Bristol-Myers Squibb (BMY.US) has achieved success in phase III clinical trials for two experimental drugs intended to treat a rare endocrine cancer and a fatal lung disease, giving a boost to the pharmaceutical company’s new product pipeline. Encouraged by this news, as of press time, Bristol-Myers Squibb’s US shares rose nearly 4% in pre-market trading on Monday.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Earnings Preview | The "buyer strike" in the tech sector is spreading; if Cisco (CSCO.US) guidance falls short of expectations, it could be yet another blow to tech stock sentiment

Cisco will release its financial report on November 12. The market expects EPS to increase by 33% year-on-year and revenue to reach $18.09 billion. The focus will be on AI orders and the integration with Splunk.

智通财经•2026/11/09 03:36